All regulations
Nonrulemaking
FDA
FDA-2026-E-4490
Patent Term Application for ADQUEY (dilfamilast), Patent No. RE46,792
Documents
2
Comments
0
Key Dates
Comment Period OpensApr 27, 2026
Documents
Keywords
CDER
Otsuka Pharmaceutical Co Ltd
Sughrue Mion PLLC
Patent Term Application for ADQUEY (dilfamilast)
Patent No RE46792
OPEN
Data from Regulations.gov